Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Fei-Teng Lu"'
Autor:
Fan Luo, Kang-mei Zeng, Jia-xin Cao, Ting Zhou, Su-xia Lin, Wen-juan Ma, Yun-peng Yang, Zhong-han Zhang, Fei-teng Lu, Yan Huang, Hong-yun Zhao, Li Zhang
Publikováno v:
Lipids in Health and Disease, Vol 20, Iss 1, Pp 1-14 (2021)
Abstract Background Cancer patients often exhibit chemotherapy-associated changes in serum lipid profiles, however, their prognostic value before and after adjuvant chemotherapy on survival among non-small-cell lung cancer (NSCLC) patients is unknown
Externí odkaz:
https://doaj.org/article/daae78ede35d4890bd30b6991daf3401
Autor:
Fan Luo, Fei-Teng Lu, Miao-Zhen Qiu, Ting Zhou, Wen-Juan Ma, Min Luo, Kang-Mei Zeng, Qiu-Yun Luo, Wen-Tao Pan, Lin Zhang, Zeng-Fei Xia, Zhong-Han Zhang, Jia-Xin Cao, Hong-Yun Zhao, Li Zhang, Da-Jun Yang
Publikováno v:
Cell Death and Disease, Vol 12, Iss 8, Pp 1-14 (2021)
Abstract Advanced nasopharyngeal carcinoma (NPC) has a poor prognosis, with an unfavorable response to palliative chemotherapy. Unfortunately, there are few effective therapeutic regimens. Therefore, we require novel treatment strategies with enhance
Externí odkaz:
https://doaj.org/article/c8fd1d13c348483b94e5ed6a0209e578
Autor:
Fan Luo, Kang‐mei Zeng, Zhong‐han Zhang, Ting Zhou, Jian‐hua Zhan, Fei‐teng Lu, Yun‐peng Yang, Yan Huang, Li Zhang, Hong‐yun Zhao
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 2, Pp n/a-n/a (2020)
Externí odkaz:
https://doaj.org/article/8577054f452d4d90882f6f50557582eb
Autor:
Qiu‐Yun Luo, Tian Di, Zhi‐Gang Chen, Jian‐Hong Peng, Jian Sun, Zeng‐Fei Xia, Wen‐Tao Pan, Fan Luo, Fei‐Teng Lu, Yu‐Ting Sun, Li‐Qiong Yang, Lin Zhang, Miao‐Zhen Qiu, Da‐Jun Yang
Publikováno v:
Cancer Science. 113:3330-3346
Colon cancer is the third most common cancer and the second leading cause of cancer-related death worldwide. Dysregulated RNA splicing factors have been reported to be associated with tumorigenesis and development in colon cancer. In this study, we i
Autor:
Fan Luo, Fei-Teng Lu, Jia-Xin Cao, Wen-Juan Ma, Zeng-Fei Xia, Jian-Hua Zhan, Kang-Mei Zeng, Yan Huang, Hong-Yun Zhao, Li Zhang
Publikováno v:
Cancer Letters. 531:39-56
The response to immune checkpoint inhibitors (ICIs) monotherapy remains unsatisfactory in patients with NSCLC. Thus, combining ICIs with other potential modalities is of great significance to enhance the response of single drug alone. Here, we identi
Publikováno v:
Cancer Research. 82:6094-6094
Background: Although immune checkpoint inhibitors (ICI) included PD-1/PD-L1 have demonstrated durable therapeutic responses in some cases, a significant portion of patients with cancer remain nonresponsive (e.g. only ~20% with anti-PD-1 in lung cance
Autor:
Fan Luo, Fei-teng Lu, Miao-zhen Qiu, Wen-tao Pan, Lin Zhang, Hong-yun Zhao, Li Zhang, Da-jun Yang
Publikováno v:
Cancer Research. 82:5191-5191
The main challenges for immune checkpoint inhibitors (ICIs) are ascribable to tumor immunosuppressive microenvironment and a lack of sufficient activated CD8+ T cell infiltration. Modifying tumor-associated macrophages (TAMs) strategies have attracte
Autor:
Fei Teng Lu, Hong Yun Zhao, Fan Luo, Li Zhang, Lin Zhang, Wen Tao Pan, Miao Zhen Qiu, Da Jun Yang
Publikováno v:
Cancer Research. 81:439-439
BCL-2 inhibitor APG-2575 promotes anti-tumor efficacy of immune checkpoint blockade through converting tumor-associated macrophages into M1 phenotype in non-small cell lung cancer Background: Immune checkpoint inhibitors (ICIs) has received approval